Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Pulmonary Hypertension

Free Subscription 27.03.2023 1 Am Heart J 1 Am J Med Sci 1 Am J Otolaryngol 1 Am J Physiol Heart Circ Physiol 1 Am J Respir Cell Mol Biol 2 Am J Respir Crit Care Med 1 bioRxiv 1 Cardiology 1 Cardiovasc Res 1 Circ Heart Fail 1 Clin Exp Hypertens 1 Clin Res Cardiol 1 Cochrane Database Syst Rev 1 Eur Heart J Cardiovasc Imaging 1 Eur Heart J Case Rep 1 Eur J Cardiothorac Surg 2 Front Cardiovasc Med 1 Front Pediatr 1 Heart Fail Clin 1 Heliyon 1 Int J Biochem Cell Biol 1 Int Urol Nephrol 4 J Am Heart Assoc 1 J Cardiopulm Rehabil Prev 1 J Cardiovasc Med (Hagerstown) 1 J Clin Immunol 1 J Fam Pract 1 J Heart Lung Transplant 1 J Pain Symptom Manage 2 J Pediatr 2 Liver Transpl 1 Mol Pharmacol 1 Pediatr Pulmonol 1 Pediatr Res 1 Pharmacol Ther 1 Pulm Circ 2 Respir Med 1 Respir Res 1 Toxicol Appl Pharmacol 1 Turk J Med Sci

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. BENINCASA G, Napoli C, Loscalzo J, Maron BA, et al
   Pursuing Functional Biomarkers in Complex Disease: Focus on Pulmonary Arterial Hypertension.
   Am Heart J. 2022 Dec 21:S0002-8703(22)00330-1. doi: 10.1016/j.ahj.2022.
   PubMed         Abstract available
   
   

   
   Am J Med Sci

2. HEGAZY Y, Aryan M, Panchani N, Reif M, et al
   The correlation in echocardiogram to right heart catheterization in identifying pulmonary hypertension as a barrier to liver transplantation.
   Am J Med Sci. 2023 Mar 16:S0002-9629(23)01070.
   PubMed         Abstract available
   
   

   
   Am J Otolaryngol

3. MONTALBARON MB, Tian L, Yu VX, Awad MI, et al
   Multi-institutional search for patient factors associated with adverse events following tracheotomy.
   Am J Otolaryngol. 2023;44:103773.
   PubMed         Abstract available
   
   

   
   Am J Physiol Heart Circ Physiol

4. BROWN RD, Hunter KS, Li M, Frid MG, et al
   Functional and Molecular Determinants of Right Ventricular Response to Severe Pulmonary Hypertension in a Large Animal Model.
   Am J Physiol Heart Circ Physiol. 2023 Mar 24. doi: 10.1152/ajpheart.00614.2022.
   PubMed         Abstract available
   
   

   
   Am J Respir Cell Mol Biol

5. HU CJ, Laux A, Gandjeva A, Wang L, et al
   The Effect of HIF Inhibition on the Phenotype of Fibroblasts in Human and Bovine Pulmonary Hypertension.
   Am J Respir Cell Mol Biol. 2023 Mar 21. doi: 10.1165/rcmb.2022-0114.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

6. OLIVEIRA SD
   Cardiopulmonary Pathogenic Networks: Unveiling the Gut-Lung Microbiome Axis in Pulmonary Arterial Hypertension.
   Am J Respir Crit Care Med. 2023;207:655-657.
   PubMed        
   
   
7. MOUTSOGLOU DM, Tatah J, Prisco SZ, Prins KW, et al
   Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.
   Am J Respir Crit Care Med. 2023;207:740-756.
   PubMed         Abstract available
   
   

   
   bioRxiv

8. JANI V, Aslam MI, Fenwick AJ, Ma W, et al
   Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure with Pulmonary Hypertension.
   bioRxiv. 2023 Mar 12:2023.03.09.531988. doi: 10.1101/2023.03.09.531988.
   PubMed         Abstract available
   
   

   
   Cardiology

9. LIN Y, Pang L, Huang S, Shen J, et al
   A nomogram for predicting 3-year mortality in patients with pulmonary hypertension due to left heart failure: A retrospective analysis of a prospective registry study.
   Cardiology. 2023 Mar 23. doi: 10.1159/000530206.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

10. FAYYAZ AU, Sabbah MS, Dasari S, Griffiths LG, et al
    Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension.
    Cardiovasc Res. 2023;119:268-282.
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

11. MARTENS P, Bhattacharya S, Longinow J, Ives L, et al
    Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis.
    Circ Heart Fail. 2023 Jan 25:e010078. doi: 10.1161/CIRCHEARTFAILURE.122.010078.
    PubMed         Abstract available
    
    

    
    Clin Exp Hypertens

12. DONG J, Jiang XM, Xie DJ, Luo J, et al
    Establishment of a canine model of pulmonary arterial hypertension induced by dehydromonocrotaline and ultrasonographic study of right ventricular remodeling.
    Clin Exp Hypertens. 2023;45:2190503.
    PubMed         Abstract available
    
    

    
    Clin Res Cardiol

13. BOXHAMMER E, Kletzer J, Kellermair J, Scharinger B, et al
    CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in patients with severe aortic valve stenosis.
    Clin Res Cardiol. 2023 Mar 20. doi: 10.1007/s00392-023-02182.
    PubMed         Abstract available
    
    

    
    Cochrane Database Syst Rev

14. MORRIS NR, Kermeen FD, Jones AW, Lee JY, et al
    Exercise-based rehabilitation programmes for pulmonary hypertension.
    Cochrane Database Syst Rev. 2023;3:CD011285.
    PubMed         Abstract available
    
    

    
    Eur Heart J Cardiovasc Imaging

15. KNIGHT DS, Karia N, Cole AR, Maclean RH, et al
    Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study.
    Eur Heart J Cardiovasc Imaging. 2023;24:463-471.
    PubMed         Abstract available
    
    

    
    Eur Heart J Case Rep

16. TAMURA H, Hosokawa S, Yuba K, Kishi K, et al
    Rescue balloon pulmonary angioplasty for worsening chronic thromboembolic pulmonary hypertension with essential thrombocythaemia and the JAK2-V617F mutation: a case report.
    Eur Heart J Case Rep. 2023;7:ytad106.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

17. VAN RAEMDONCK D, Vos R, Verleden GM, Ceulemans LJ, et al
    Living-donor lobar lung transplantation for pulmonary hypertension: living on the edge?
    Eur J Cardiothorac Surg. 2023 Mar 23:ezad097. doi: 10.1093.
    PubMed        
    
    

    
    Front Cardiovasc Med

18. ASLLANAJ B, Benge E, Bae J, McWhorter Y, et al
    Fluid management in septic patients with pulmonary hypertension, review of the literature.
    Front Cardiovasc Med. 2023;10:1096871.
    PubMed         Abstract available
    
    
19. XIAO M, Lai D, Yu Y, Wu Q, et al
    Pathogenesis of pulmonary hypertension caused by left heart disease.
    Front Cardiovasc Med. 2023;10:1079142.
    PubMed         Abstract available
    
    

    
    Front Pediatr

20. FUKASAWA Y, Yamamoto H, Ito M, Saito A, et al
    Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease.
    Front Pediatr. 2023;11:1116434.
    PubMed         Abstract available
    
    

    
    Heart Fail Clin

21. SCHUSTER M, Muller J, Schwarz EI, Saxer S, et al
    Oxygen Therapy in Pulmonary Vascular Disease: A Systematic Review, Meta-Analysis, and Comment.
    Heart Fail Clin. 2023;19.
    PubMed         Abstract available
    
    

    
    Heliyon

22. HUSSAIN T, Chai L, Wang Y, Zhang Q, et al
    Activation of PPAR-gamma prevents TERT-mediated pulmonary vascular remodeling in MCT-induced pulmonary hypertension.
    Heliyon. 2023;9:e14173.
    PubMed         Abstract available
    
    

    
    Int J Biochem Cell Biol

23. XUN M, Zhang J, Wu M, Chen Y, et al
    Long non-coding RNAs: The growth controller of vascular smooth muscle cells in cardiovascular diseases.
    Int J Biochem Cell Biol. 2023;157:106392.
    PubMed         Abstract available
    
    

    
    Int Urol Nephrol

24. BORBA GC, Andrade FP, de Souza Ferreira T, Pinotti AFF, et al
    Estimation of pulmonary artery systolic pressure in hemodialysis patients and its association with cardiorespiratory fitness and pulmonary function.
    Int Urol Nephrol. 2023;55:961-968.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

25. LAMMERS AE, Marek J, Diller GP, Haworth SG, et al
    Prognostic Value of Transthoracic Echocardiography in Children With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e023118.
    PubMed         Abstract available
    
    
26. FORTMEIER V, Lachmann M, Unterhuber M, Stolz L, et al
    Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation.
    J Am Heart Assoc. 2023;12:e028737.
    PubMed         Abstract available
    
    
27. CHANG KY, Giorgio K, Schmitz K, Walker RF, et al
    Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e027559.
    PubMed         Abstract available
    
    
28. XING Y, Qi J, Cheng X, Song X, et al
    Circ-myh8 Promotes Pulmonary Hypertension by Recruiting KAT7 to Govern Hypoxia-Inducible Factor-1alpha Expression.
    J Am Heart Assoc. 2023 Mar 21:e028299. doi: 10.1161/JAHA.122.028299.
    PubMed         Abstract available
    
    

    
    J Cardiopulm Rehabil Prev

29. BARRET T, Degano B, Bouvaist H, Pison C, et al
    Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions.
    J Cardiopulm Rehabil Prev. 2023 Mar 21. doi: 10.1097/HCR.0000000000000755.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Med (Hagerstown)

30. ZUIN M, Bilato C, Rigatelli G, Quadretti L, et al
    Trends in age-specific and sex-specific pulmonary hypertension mortality in Italy between 2005 and 2017.
    J Cardiovasc Med (Hagerstown). 2023 Mar 20. doi: 10.2459/JCM.0000000000001457.
    PubMed         Abstract available
    
    

    
    J Clin Immunol

31. FOGEL LA, Grady RM, He M, Kitcharoensakkul M, et al
    Steroid-Responsive Pulmonary Hypertension in a Pediatric Patient with Chronic Granulomatous Disease and Histoplasmosis.
    J Clin Immunol. 2023 Mar 24. doi: 10.1007/s10875-023-01473.
    PubMed        
    
    

    
    J Fam Pract

32. SINGH M, Berkey F, Fragin J, Grine K, et al
    Pulmonary hypertension: An update of Dx and Tx guidelines.
    J Fam Pract. 2023;72:72-83.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

33. HUANG Y, Zhang QZ, Lv SJ
    Comments and opinions regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension".
    J Heart Lung Transplant. 2023 Mar 20:S1053-2498(23)01788.
    PubMed        
    
    

    
    J Pain Symptom Manage

34. BROWN CE, Steiner JM, Leary PJ, Curtis JR, et al
    A World of Maximalist Medicine: Physician Perspectives on Palliative Care and End-of-life for Patients With Pulmonary Arterial Hypertension.
    J Pain Symptom Manage. 2023;65:e329-e335.
    PubMed         Abstract available
    
    

    
    J Pediatr

35. FRANKLIN SD, Fierro J, Hysinger EB, Phinizy PA, et al
    Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Samples of Children with Bronchopulmonary Dysplasia.
    J Pediatr. 2023;253:79-85.
    PubMed         Abstract available
    
    
36. LEVIN JC, Annesi CA, Williams DN, Abman SH, et al
    Discharge Practices for Infants with Bronchopulmonary Dysplasia: A Survey of National Experts.
    J Pediatr. 2022 Sep 17. pii: S0022-3476(22)00822.
    PubMed         Abstract available
    
    

    
    Liver Transpl

37. KROWKA MJ, Kamath PS
    Portopulmonary hypertension: May we agree to disagree?
    Liver Transpl. 2023;29:349-350.
    PubMed        
    
    
38. JOSE A, Kopras EJ, Shah SA, Elwing JM, et al
    Portopulmonary hypertension practice patterns after liver transplantation.
    Liver Transpl. 2023;29:365-376.
    PubMed         Abstract available
    
    

    
    Mol Pharmacol

39. GAO J, Yin H, Dong Y, Wang X, et al
    A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction.
    Mol Pharmacol. 2023;103:241-254.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

40. UCROS S, Aparicio C, Castro-Rodriguez JA, Ivy D, et al
    High altitude pulmonary edema in children: A systematic review.
    Pediatr Pulmonol. 2023;58:1059-1067.
    PubMed         Abstract available
    
    

    
    Pediatr Res

41. EL-KHUFFASH A, Mullaly R, McNamara PJ
    Patent ductus arteriosus, bronchopulmonary dysplasia and pulmonary hypertension-a complex conundrum with many phenotypes?
    Pediatr Res. 2023 Mar 18. doi: 10.1038/s41390-023-02578.
    PubMed        
    
    

    
    Pharmacol Ther

42. BEKEDAM FT, Goumans MJ, Bogaard HJ, de Man FS, et al
    Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension.
    Pharmacol Ther. 2023 Mar 18:108389. doi: 10.1016/j.pharmthera.2023.108389.
    PubMed         Abstract available
    
    

    
    Pulm Circ

43. RAWLINGS GH, Novakova B, Armstrong I, Thompson AR, et al
    Can self-compassion help us better understand the impact of pulmonary hypertension on those with the condition and their carers? A cross-sectional analysis.
    Pulm Circ. 2023;13:e12208.
    PubMed         Abstract available
    
    

    
    Respir Med

44. HELD M, Pfeuffer-Jovic E, Wilkens H, Guder G, et al
    Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20 mm Hg: Retrospective analysis from data of a prospective PE aftercare program.
    Respir Med. 2023;210:107177.
    PubMed         Abstract available
    
    
45. CARLOZZI LN, Lee J, Barros LM, Buber Y, et al
    Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience.
    Respir Med. 2023 Mar 17:107215. doi: 10.1016/j.rmed.2023.107215.
    PubMed         Abstract available
    
    

    
    Respir Res

46. YANG Z, Li P, Yuan Q, Wang X, et al
    Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.
    Respir Res. 2023;24:92.
    PubMed         Abstract available
    
    

    
    Toxicol Appl Pharmacol

47. ZHANG X, Yang Z, Su S, Nan X, et al
    Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3beta-cyclin axis.
    Toxicol Appl Pharmacol. 2023;466:116478.
    PubMed         Abstract available
    
    

    
    Turk J Med Sci

48. DUZGUN Z, Kayikcioglu LM, Aktan C, Bara B, et al
    Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.
    Turk J Med Sci. 2023;53:130-141.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: